Isabel Foley - 03 Mar 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)

Reporting relationship: Group General Counsel
Issuer ticker: CRH
Reported as of: 03 Mar 2025
Net transaction value: -$1,927,658
SEC form: 4
Accepted by SEC: 05 Mar 2025, 16:30:10 UTC
Prior SEC filing: 02 Jan 2025
Source filing: View source filing
Reporting owner signature: Cot Eversole, Attorney-in-Fact for Isabel Foley

Key filing fact

Isabel Foley filed Form 4 for CRH PUBLIC LTD CO (CRH) on 05 Mar 2025.

Key facts

This page summarizes Isabel Foley's Form 4 filing for CRH PUBLIC LTD CO (CRH).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2025, 16:30.

Change

Previous filing in this sequence was filed on 02 Jan 2025.
Current net transaction value: -$1,927,658.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRH transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +32,461
Change %: +89%
Price: $0.000000
Shares after: 68,905
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F1

CRH transaction

Ordinary Shares

Options Exercise

Transaction value: $0
Shares: +3,867
Change %: +5.6%
Price: $0.000000
Shares after: 72,772
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F2

CRH transaction

Ordinary Shares

Tax liability

Transaction value: $1,927,658
Shares: -20,242
Change %: -28%
Price: $95.23
Shares after: 52,530
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRH transaction Derivative

Deferred Share Award

Options Exercise

Transaction value: $0
Shares: -3,543
Change %: -32%
Price: $0.000000
Shares after: 7,394
Date: 03 Mar 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 3,543
Exercise price: $0.000000
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 2,717 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").

Footnote F2

Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 3,867 shares vested on March 3, 2025, including the award of 324 additional Ordinary Shares as dividend equivalents. Subject to the determination of the Compensation Committee, the remaining awards of 4,307 shares and 3,087 shares are expected to vest in March 2026 and March 2027, respectively. In accordance with the DSB Plan Rules, dividend equivalents will apply to these awards and, to the extent awarded, will be reported at the time of vesting.

Footnote F3

Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned awards

Footnote F4

The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $92.75 and $ 98.705 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.